Summary Slide.png (66.34 kB)

Golimumab as First, Second or at Least Third Biologic Agent in Patients With Rheumatoid Arthritis, Psoriatic Arthritis or Ankylosing Spondylitis -Post Hoc Analysis of a Non-Interventional Study in Germany

Download (66.34 kB)
figure
posted on 09.04.2020, 15:59 by Klaus Krüger, Gerd Rüdiger Burmester, Siegfried Wassenberg, Matthias. H. Thomas

The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).

© The authors, CC-BY-NC 2020.

History

Exports